• Environmental Analysis Health and Toxicology
• /
• 제2권1_2호
• /
• pp.1-12
• /
• 1987

• Environmental Analysis Health and Toxicology
• /
• 제4권3_4호
• /
• pp.87-95
• /
• 1989

• Environmental Analysis Health and Toxicology
• /
• 제7권3_4호
• /
• pp.1-15
• /
• 1992

• 한국환경성돌연변이발암원학회:학술대회논문집
• /
• 한국환경성돌연변이발암원학회 2002년도 Molecular and Cellular Response to Toxic Substances
• /
• pp.165-165
• /
• 2002

• 한국독성학회:학술대회논문집
• /
• 한국독성학회 2003년도 춘계학술대회 논문집
• /
• pp.87-87
• /
• 2003

Various parameters of blood may be fluctuated by environmental factors such as transportation stress including diet, temperature, and so on). Thirty five 3- to 5 years-old cynomolgus monkeys were imported from Japan to evaluate potential toxic effect of a new biopharmaceutical. (omitted)

• 한국환경성돌연변이발암원학회:학술대회논문집
• /
• 한국환경성돌연변이발암원학회 2002년도 Current Trends in Toxicological Sciences
• /
• pp.128-128
• /
• 2002

• 한국독성학회:학술대회논문집
• /
• 한국독성학회 2003년도 추계학술대회
• /
• pp.178-178
• /
• 2003

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), a prototype of many halogenated aromatic hydrocarbons, is a ubiquitous, persistent environmental contaminant and the most powerful carcinogen categorized by IARC. It is display high toxicity in animals and is associated with several cancers in human. Although the mechanism of carcinogenesis by TCDD is unclear, it is considered to be a non-genotoxic and rumor promoter.(omitted)

• 한국환경독성학회:학술대회논문집
• /
• 한국환경독성학회 2004년도 춘계학술대회
• /
• pp.80-80
• /
• 2004

• 한국환경독성학회:학술대회논문집
• /
• 한국환경독성학회 2004년도 춘계학술대회
• /
• pp.81-81
• /
• 2004

• 한국독성학회:학술대회논문집
• /
• 한국독성학회 2001년도 International Symposium on Dietary and Medicinal Antimutgens and Anticarcinogens
• /
• pp.162-162
• /
• 2001

Phytoestrogens produced naturally by either plants or their seeds are three main classes of phytoestrogens: isoflavone, lignan and coumestan. Phytoestrogens can have both agonist and antagonist action of estrogenic activity. It is believed that phytoestrogens with agonist and antagonist action of estrogenic activity may reduce the risk of breast cancer, in addition to may reduce the risk of osteoporesis by therapeutic agent of breast cancer.(omitted)